Oncology Medical News about children with medulloblastoma;glutathione S-transferase M1 and T1 polymorphisms

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma
Neuro-Oncology, 06/12/09

Nadia Barahmani N et al. – A study of whether glutathione S-transferases (GSTs) polymorphisms are in part responsible for individual differences in toxicity and responses in pediatric medulloblastoma concludes that GSTM1 and GSTT1 polymorphisms may predict adverse events, including cognitive impairment after therapy, in pts with medulloblastoma.

Methods

Study of the relationship between GSTM1 and GSTT1 polymorphisms and survival and toxicity in 42 children with medulloblastoma
Kaplan-Meier analyses to determine if GST polymorphisms related to progression-free survival
Logistic regression to explore associations between GST polymorphisms and occurrence of ≥grade 3 (Gr 3) myelosuppression, ototoxicity, nephrotoxicity, neurotoxicity, and intellectual impairment.

Results

Pts with ≥1 null genotype had a 4.3, 3.7, and 6.4 times increased risk for any Gr 3 toxicity, any Gr 3 toxicity excluding peripheral neuropathy, and any Gr 3 toxicity requiring omission or cessation of chemotherapy, respectively
Pts with ≥1 null genotype had an average 27.2, 29, and 21.7 lower full-scale, performance, and verbal intelligence quotient scores, respectively

<< Previous
Increased incidence of papillary thyroid microcarcinoma with...

Next >>
Differential effect of sunitinib on the distribution of...